GlassScriptPhysician profile
Michael Wade Shrader
NPI 1922040161
$14,331.62
in general payments reported to CMS, 2019-2025
8 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,084 · 2020: $64.80 · 2021: $37.08 · 2022: $399 · 2023: $489 · 2024: $5,132 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,918 · Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,917.50 |
| Food and Beverage | $829.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $10,655.45 | 2019-2024 | |
| Medical Device Business Services, INC. | $2,390.58 | 2019-2024 | Expedium, Expedium Verse |
| Depuy Synthes Sales INC. | $734.49 | 2019-2025 | Expedium, Velys |
| Biocomposites INC | $247.53 | 2022-2024 | Stimulan |
| Stryker Corporation | $158.17 | 2023-2024 | Capri Corpectomy Cage System, Bio Dbm, Monterey Al |
| Sanara Medtech INC. | $84.38 | 2023 | Celleraterx |
| Eclipse Technology Solutions INC. | $32.66 | 2025 | |
| Smith+Nephew, INC. | $28.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shrader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.